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Abstract
A case with prolonged implanted breast prosthesis experienced a prolonged capsular contracture complicated with pleural effusion. A complete
capsular removal proceeded instead of removal of the prosthesis solely. The present case aimed to share experiences that may add to the scientific
horizon regarding the rare complications of breast prosthesis and rarely reported.
Keywords: capsular contracture, breast prosthesis, pleural effusion

Introduction
No certainty to date about how long breast prosthesis may be safely
implanted remains the problem encountered in daily practice. The
lifetime of breast prosthesis has no expiry date as the medicine is. Indeed,
the lifetime of breast prosthesis referred to the question asked by those
who need breast augmentation. Some surgeon decides to replace after
10–20 years, while as others proposed earlier, but the reason not
supported by strong evidence. In addition to lifetime, a different problem
encountered where the complication found, such as capsule contracture,1
infection, inflammatory and immune responses, or even malignancy2
have been reported recommends prosthesis removal. Pleural effusion,
which is an uncommon, rare complication following mammary bag
rupture, has been first reported by Steven (1987).3 More than 25 years
later, Shaik et al. (2015) published their finding, which is the recent
report, namely foreign body reaction to silicone material of gel–filled
breast prosthesis, that was ruptured.4
In this report, unusual complications of capsular contracture in
prolonged implanted breast prosthesis, namely melted gel–filled silicone
breast implant covered by thick calcified capsular contracture
complicated with pleural effusion presented that may contribute to the
literature.

weight remains 45–46 kg for the last 20 years. No family history of
malignancy. On further history–taking, she underwent breast prosthesis
implantation for more than thirty years. No accurate information about
the type of prosthesis implanted. The abnormal shape of the breast
realized for more than 20 years, and no action has been taken to solve
this problem.
On physical examination, she looked cachectic, alert, no respiratory
distress, and a stable hemodynamic. Breasts showed abnormal
appearance (see figure 1 below) with normal skin over the chest,
lobulated, firms, well–demarcated, and no pain. The laboratory findings
showed hemoglobin content 3.5 g/dL, white blood cells count 3,500
cell/mm3, platelet count 185,000 cells/mm3. Serum albumin of 1.5 g/dL.
C–Reactive Protein 92 mg/L. On CT scan, a pleural effusion denoted
(see figure 2), and the effusion diminished following a tapping before
surgery (see figure 3). Cytology has not proceeded as a correlation to
malignancy was out of the thinking.

Case illustration
A female of 61 years referred by the pulmonologist with a history of
persistent pleural effusion. A repetitive tapping proceeded for the last
two months. The effusion developed progressively over the previous
two weeks requires frequent tapping. The condition worsened in the past
five days, and the patient was labelled as sepsis. No tuberculosis and
HIV infection in history–taking confirmed by the laboratory test. Body

Figure 1. Female 61 years with prolonged capsular contracture in prolonged
implanted breast prosthesis. The abnormal shape of the breasts is shown.
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Figure 2. Pleural effusion clearly showed in axial (A) and sagittal projection (B).
A blurred area in the intercostal space with a defect in the bag alignment of the
right side denoted (arrows).

Figure 4. Surgical removal of the prosthesis. A. Capsulotomy proceeded through
the inframammary approach. A. thick calcified capsule with fragile calcified
material. B. Showing an intact prosthesis following capsulotomy. C. Removal of
the prosthesis was difficult as the prosthesis melted as if a glue. D. Showing the
calcified fibrotic capsule.

Discussion
Figure 3. Chest ray took a day before surgery, showing diminished effusion. The
capsular contracture clearly showed.

Simultaneously with blood including platelet transfusion, the surgical
prosthesis removal planned under general anesthesia proceeded for
source control. No prophylactic antibiotic given, but those given by the
pulmonologist continued. The procedure started on the right side.
Intraoperatively, a thick inelastic fibrous capsule found, and a
capsulotomy proceeded (see figure 4A). It was difficult to remove the
prosthesis solely intact as it melted (see figure 4BC). The thick capsule
observed (see figure 4D), and to this finding, total capsulectomy
proceeded — the complete removal procedure employed on the left side
as well. Both pectoral muscles (major and minor) and its fascia as that
thin (atrophic), and intercostal as well let it challenge to recognize. The
intercostal muscles had the same boat. The bag of this smooth–surfaced
prosthesis looks intact, but the gel–filled content damaged (see figure 4).
Intraoperatively, no active bleeding, but diffuse capillary oozing. A
vacuum drain inserted and keep maintained for two days postoperatively
and discharged on the third postoperative days; clinically improved. No
bruising, nor hematoma and the stitches removed two weeks
postoperatively. No surgical complication — no progression of the
pleural effusion that needs tapping until 4th postoperative weeks.
Unfortunately, in the next two weeks after the last follow up, nobody
knew the subject died while she sleeps at home — no family nor relative
and the guardian he had, thus the author unable to provide the consent.
Pathology findings showed a dense collagen distribution in the capsule
and loose collagen ones. Amorphic bodies found discretely, and
calcified field denoted massively — no features of malignancy identified
in the fields.

The present study is reporting a case enfacing problem of a prolonged
implanted breast prosthesis (30 years) complicated with capsular
contracture with non–ruptured bag, and pleural effusion. The capsular
contracture realized for 20 years (or the tenth year after prosthesis
implantation), which not treated.
The term prolonged referred to a relative because no definite lifetime
defined for how long the prothesis may safely be implanted, even though
attributed to inert material. Many argue for ten years but somehow not
supported by strong evidence. Thirty years implanted prosthesis referred
to an unusual event.
Capsular contracture
The capsular contracture is first reported somewhere in the 1990s as a
complication that after prosthesis implantation and had been widely
studied recently. It was Spear (1995), the one who classifies,5 and lately,
Headon and colleague (2015) reviewed it comprehensively.1 There are
known factors responsible for the development of capsule formation,
which, in turn, develops into a contracture at a later date. Firstly,
inadequately evacuated hematoma resolved with the organization of
blood clots with the formation of a fibrous tissue resembling the capsule
surrounding the prosthesis. Studies showed that following implantation,
a thin gel–like substance comprises matrix proteins covering the
prosthesis – namely, biofilms. Based on the analysis of the biofilms, it
thought to be responsible for later capsular contracture. The other studies
reporting the biofilms referred to the best media for the colonization and
the development of bacteria.6–8 The following condition explains why
the infection is difficult to treat until the implant removed.
It is clearly understood that the body's response by mobilizing more
fibroblasts to the films leading to the capsular formation in the presence
29
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of prosthesis – which is a foreign body – and thickening, even
contractures. Matrix metalloproteinase plays an essential role in capsular
contracture.9 The stigmata of chronic inflammation let the formation of
granulomatous tissue, thickening calcified fibrous tissue, and even
ossification.7 Secondly, the surface of the mammary prosthesis. Studies
show that smooth–surfaced prosthesis, as in the presented case, has a
high tendency to have capsular contracture compared to the textured
ones. For this reason, textured – surface prosthesis referred to the first–
choice prosthesis, recently.10 Thirdly, the condition described in the
earlier paragraph logically occurs should there is a rupture of the
prosthesis bag. Even though silicones approved as safety material, the
gel–filled, which is a foreign body, may induce the inflammatory
response. The longer the inflammatory process continues, the higher the
tendency to the development of capsular contracture. Should it have left
unmanaged – which is a complete prosthesis plus capsule removal –
then the inflammatory response extends to the adjacent tissue and, this
phenomenon confirmed by the increased C–reactive protein. This brief
description is not trying to repeat what Headon comprehensively
described previously but summarizing the points that may lead us to the
link to the later complication.
Pleural effusion
Pleural effusion as a complication following mammary prosthesis
implantation is extremely rare. To date, only four articles were reporting
such a complication. It was Steven (1987), who is the first reporting this
infrequent complication,3 followed by Taupmannn and Adler (1993),11
Hirmand et al. (1994).12, and Shaik et al. (2015).4 Those four articles
were reporting the case with pleural effusion associated with the rupture
of the mammary bag. It clearly understood that the body's response (in
this case, pleural effusion) to silicone material (foreign body) following
a bag rupture, it is quite logic. However, the elaboration of pleural
involvement as a response to foreign bodies in the non–ruptured bag
needs more attention and should be addressed with criticism.
There are two possibilities regarding pleural involvement in this case.
Firstly, a direct impact. It assumed based on the intraoperative findings
showing disconfigured adjacent tissue. Muscular atrophy (both of
pectoral muscles and its fascia, intercostals, and its fascia of the areolar
segment) let the anatomical barrier to the pleural cavity is not well
resembled. This anatomical defect found posterior to the capsule and
may respond to pleural involvement. CT scan showing a blurred area
suggesting pleural involvement (figure 2).
Secondly, the possibility based on the theory. The lymphatic vessel
involvement associated with the endothelium builds up the vessel wall,
as the Centrepoint of inflammation.13,14 The lymphatic vessels in the
areola and it's efferent branches collected into two trunks that pass to the
pectoral group of axillary glands. The vessels which drain the medial
part of the breast pierce the thoracic wall and end in the sternal glands.
At the same time, a vessel has occasionally been seen to emerge from
the upper part of the breast and, piercing the pectoralis major, terminate
in the sub clavicular glands. To this anatomical base, pleural
involvement in this chronic inflammatory response to the prosthesis may
be understood. To the second possibility, no evidence provided, as we
didn't take a specimen from intercostal space, as it not ethical.
The subject experienced a chronic inflammatory response that us a lot of
energy leading to body wasting, low–level albumin, as well as a defect
in the immune system. The low platelet count reinforces this fact and is

no correlation to infection (sepsis), as many surgeons thought.15 In such
a condition, the capsule referred to as a burden has to be removed
entirely.
The question of how long a prosthesis might keep implanted – as a
common question and frequently asked questions of a candidate before
breast augmentation – remains unanswered. To date, there is no basic
science nor strong evidence that could answer such a problem, but
clinical reports of the level four evidence.
Summary
This case presented a valuable clinical experience in management a rare
complication of prolonged capsular contracture in a prolonged
implanted breast prosthesis. The key message to be delivered was a
prolonged implanted prosthesis that should be avoided, even though
there was no definitive nor strong evidence showing the exact lifetime.
Capsular contracture as a common complication following implantation
breast prosthesis should be prevented and managed immediately
through a complete capsule removal to avoid further complications, as
in this case.
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